FIBROSCAN
FIBROSCAN
“Where the art of medicine is loved, there is also love for humanity” - Hippocrates
One of the multicenter studies across 101 Indian cities estimated the prevalence rate of NAFLD as 56.5% (n = 522) among 924 patients with type 2 DM.1 Multiple studies from different centers of India have reported alcohol to be the commonest cause of cirrhosis with prevalence ranging from 30% to 70% of all cases of cirrhosis.2
A number of chronic liver diseases are reversible if they are diagnosed early and then correctly monitored and treated. Transient elastography (FibroScan) is a new, non‐invasive, rapid, and reproducible method allowing evaluation of liver fibrosis by measurement of liver stiffness.3 FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 3,500+ peer-reviewed publications and 160+ international guidelines.4
References:
1Mondal D, Das K, Chowdhury A. Epidemiology of Liver Diseases in India. Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):114-117. doi: 10.1002/cld.1177. PMID: 35355840; PMCID: PMC8958241.
2Shah AS, Amarapurkar DN. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India. J Clin Exp Hepatol. 2018 Mar;8(1):50-57. doi: 10.1016/j.jceh.2017.06.001. Epub 2017 Jun 15. PMID: 29743797; PMCID: PMC5938527.
3Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Lédinghen V. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006 Mar;55(3):403-8. doi: 10.1136/gut.2005.069153. Epub 2005 Jul 14. PMID: 16020491; PMCID: PMC1856085.
4https://www.echosens.com
Fibroscan
- Home Collection · Not Available
- Reports · 1 Day
